Sarah E. Garnish
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
The kinase domain of RIPK3 tunes its scaffolding functions.
Journal: Cell death and differentiation
Published: April 24, 2025
MLKL deficiency elevates testosterone production in male mice independently of necroptotic functions.
Journal: Cell death & disease
Published: October 29, 2024
Coxiella burnetii protein CBU2016 supports CCV expansion.
Journal: Pathogens and disease
Published: January 08, 2024
Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization.
Journal: Nature communications
Published: June 23, 2023
MLKL deficiency protects against low-grade, sterile inflammation in aged mice.
Journal: Cell death and differentiation
Published: October 12, 2022
A common human MLKL polymorphism confers resistance to negative regulation by phosphorylation.
Journal: Nature communications
Published: September 27, 2022
Rare catastrophes and evolutionary legacies: human germline gene variants in MLKL and the necroptosis signalling pathway.
Journal: Biochemical Society transactions
Published: October 12, 2021
Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell death.
Journal: iScience
Published: August 04, 2021
Add necroptosis to your asthma action plan.
Journal: Immunology and cell biology
Published: July 01, 2021
Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis.
Journal: Nature communications
Published: June 29, 2021
Last Updated: 09/26/2026